Manulife (Manufacturers Life Insurance)’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-82,668
| Closed | -$498K | – | 2952 |
|
|
2019
Q4 | $498K | Sell |
82,668
-6,433
| -7% | -$37.2K | ﹤0.01% | 2051 |
|
|
2019
Q3 | $327K | Sell |
89,101
-262
| -0.3% | -$1.01K | ﹤0.01% | 2275 |
|
|
2019
Q2 | $239K | Sell |
89,363
-1,709
| -2% | -$5.05K | ﹤0.01% | 2519 |
|
|
2019
Q1 | $269K | Sell |
91,072
-6,880
| -7% | -$16.9K | ﹤0.01% | 2297 |
|
|
2018
Q4 | $156K | Buy |
97,952
+5,621
| +6% | +$15.9K | ﹤0.01% | 2381 |
|
|
2018
Q3 | $340K | Sell |
92,331
-14,971
| -14% | -$44.6K | ﹤0.01% | 2487 |
|
|
2018
Q2 | $304K | Buy |
107,302
+3,109
| +3% | +$10.6K | ﹤0.01% | 2774 |
|
|
2018
Q1 | $386K | Buy |
104,193
+10,150
| +11% | +$33.2K | ﹤0.01% | 2509 |
|
|
2017
Q4 | $271K | Buy |
94,043
+1,868
| +2% | +$6.79K | ﹤0.01% | 2784 |
|
|
2017
Q3 | $415K | Sell |
92,175
-2,066
| -2% | -$9.17K | ﹤0.01% | 2403 |
|
|
2017
Q2 | $432K | Sell |
94,241
-880
| -0.9% | -$3.54K | ﹤0.01% | 2405 |
|
|
2017
Q1 | $401K | Buy |
95,121
+12,217
| +15% | +$50.7K | ﹤0.01% | 2340 |
|
|
2016
Q4 | $343K | Buy |
82,904
+1,600
| +2% | +$8.51K | ﹤0.01% | 2382 |
|
|
2016
Q3 | $658K | Buy |
81,304
+903
| +1% | +$7.68K | ﹤0.01% | 1901 |
|
|
2016
Q2 | $627K | Buy |
80,401
+2,391
| +3% | +$20.5K | ﹤0.01% | 1889 |
|
|
2016
Q1 | $586K | Buy |
78,010
+615
| +0.8% | +$4.5K | ﹤0.01% | 1904 |
|
|
2015
Q4 | $835 | Buy |
77,395
+756
| +1% | +$6.87K | ﹤0.01% | 1718 |
|
|
2015
Q3 | $530 | Buy |
76,639
+1,810
| +2% | +$14.7K | ﹤0.01% | 1966 |
|
|
2015
Q2 | $663 | Buy |
74,829
+4,521
| +6% | +$42.8K | ﹤0.01% | 1931 |
|
|
2015
Q1 | $694 | Buy |
70,308
+8,879
| +14% | +$111K | ﹤0.01% | 1897 |
|
|
2014
Q4 | $752 | Sell |
61,429
-2,009
| -3% | -$24.5K | ﹤0.01% | 1748 |
|
|
2014
Q3 | $634 | Buy |
63,438
+388
| +0.6% | +$3.6K | ﹤0.01% | 1843 |
|
|
2014
Q2 | $477K | Sell |
63,050
-11,166
| -15% | -$44.6K | ﹤0.01% | 2072 |
|
|
2014
Q1 | $245 | Sell |
74,216
-821
| -1% | -$2.87K | ﹤0.01% | 2575 |
|
|
2013
Q4 | $249 | Buy |
75,037
+1,233
| +2% | +$3.58K | ﹤0.01% | 2558 |
|
|
2013
Q3 | $223 | Sell |
73,804
-1,069
| -1% | -$7.33K | ﹤0.01% | 2580 |
|
|
2013
Q2 | $612K | Buy |
+74,873
| New | +$572K | ﹤0.01% | 1771 |
|
Manulife (Manufacturers Life Insurance)'s ACHN Position: Q1 2020 in Review
Manulife (Manufacturers Life Insurance) sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 82,668 shares — an estimated $498K sold.
Manulife (Manufacturers Life Insurance) first reported a position in ACHN in Q2 2013 and held it in 27 quarters. The position peaked at $658K in Q3 2016. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Manulife (Manufacturers Life Insurance) reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 82,668 Achillion Pharmaceuticals shares in Q1 2020, an estimated $498K.
- Manulife (Manufacturers Life Insurance) first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 27 quarters.
- Manulife (Manufacturers Life Insurance)'s Achillion Pharmaceuticals position peaked at $658K in Q3 2016.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2020, filed 15 May 2020.